Biochemistry · 2000 · 189 citations · 14 references
Life SciencesBiochemistryMolecular BiologyEnzymologyNeuroimmunologyProtein BiochemistryEnzyme StabilityMyelin BiochemistryProtein AnalysisProtein StructureProteolytic EnzymesProteolytic ProcessingArginine Deiminase SystemCathepsin ActivityMyelin EnzymologyMyelin ProteinsMyelin ProteolysisMyelin Structural ProteinsMyelin-associated ProteinsProteolytic Digestion Analysis
The effect of deimination of arginyl residues in bovine myelin basic protein (MBP) on its susceptibility to digestion by cathepsin D has been studied. Using bovine component 1 (C-1) of MBP, the most unmodified of the components with all 18 arginyl residues intact, we have generated a number of citrullinated forms by treatment of the protein with purified peptidylarginine deiminase (PAD) in vitro. We obtained species containing 0-9.9 mol of citrulline/mol of MBP. These various species were digested with cathepsin D, a metalloproteinase which cleaves proteins at Phe-Phe linkages. The rate of digestion compared to component 1 was only slightly affected when 2.7 or 3.8 mol of citrulline/mol of MBP was present. With 7.0 mol of citrulline/mol of MBP, a large increase in the rate of digestion occurred. No further increase was observed with 9.9 mol of citrulline/mol of MBP. The immunodominant peptide 43-88 (bovine sequence) was released slowly when 2.7 and 3.8 mol of citrulline/mol of MBP was present, but it was released rapidly when 7.0 mol of citrulline/mol of MBP was present. The dramatic change in digestion with 7.0 mol of citrulline/mol of MBP or more could be explained by a change in three-dimensional structure. Molecular dynamics simulation showed that increasing the number of citrullinyl residues above 7 mol/mol of MBP generated a more open structure, consistent with experimental observations in the literature. We conclude that PAD, which deiminates arginyl residues in proteins, decreases both the charge and compact structure of MBP. This structural change allows better access of the Phe-Phe linkages to cathepsin D. This scheme represents an effective way of generating the immunodominant peptide which sensitizes T-cells for the autoimmune response in demyelinating disease.
14
Gerard A. Schellekens, Brigit A. de Jong, F.H.J. van den Hoogen et al. · Journal of Clinical Investigation · 1998 · 1.4K citations · Full text
Elisabeth Girbal‐Neuhauser, Jean‐Jacques Durieux, Pascal Dalbon et al. · The Journal of Immunology · 1999 · 481 citations · Full text
Protein Unfolding by Peptidylarginine Deiminase
Edit Tarcsa, Lyuben N. Marekov, Giampiero Mei et al. · Journal of Biological Chemistry · 1996 · 351 citations · Full text
Myelin in multiple sclerosis is developmentally immature.
M.A. Moscarello, D. D. Wood, Cameron Ackerley et al. · Journal of Clinical Investigation · 1994 · 321 citations · Full text
Medicine, Neurology, Neuroscience +17